A double-blind multicentre comparison of diclofenac sodium and naproxen in osteoarthrosis of the hip. 1978

A Car, and I Jajić, and I Krampac, and M Vitaus, and N Zenić, and M Zivković

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009288 Naproxen An anti-inflammatory agent with analgesic and antipyretic properties. Both the acid and its sodium salt are used in the treatment of rheumatoid arthritis and other rheumatic or musculoskeletal disorders, dysmenorrhea, and acute gout. Aleve,Anaprox,Methoxypropiocin,Naprosin,Naprosyn,Naproxen Sodium,Proxen,Sodium Naproxenate,Synflex,Naproxenate, Sodium,Sodium, Naproxen
D010003 Osteoarthritis A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans. Arthritis, Degenerative,Osteoarthrosis,Osteoarthrosis Deformans,Arthroses,Arthrosis,Arthritides, Degenerative,Degenerative Arthritides,Degenerative Arthritis,Osteoarthritides,Osteoarthroses
D010648 Phenylacetates Derivatives of phenylacetic acid. Included under this heading are a variety of acid forms, salts, esters, and amides that contain the benzeneacetic acid structure. Note that this class of compounds should not be confused with derivatives of phenyl acetate, which contain the PHENOL ester of ACETIC ACID. Benzeneacetates,Benzeneacetic Acids,Phenylacetic Acids,Acids, Benzeneacetic,Acids, Phenylacetic
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004008 Diclofenac A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt. Diclophenac,Dichlofenal,Diclofenac Potassium,Diclofenac Sodium,Diclonate P,Dicrofenac,Feloran,GP-45,840,Novapirina,Orthofen,Orthophen,Ortofen,SR-38,Sodium Diclofenac,Voltaren,Voltarol,Diclofenac, Sodium,GP 45,840,GP45,840,SR 38,SR38
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females

Related Publications

A Car, and I Jajić, and I Krampac, and M Vitaus, and N Zenić, and M Zivković
April 1975, Journal of clinical pharmacology,
A Car, and I Jajić, and I Krampac, and M Vitaus, and N Zenić, and M Zivković
February 1975, Arzneimittel-Forschung,
A Car, and I Jajić, and I Krampac, and M Vitaus, and N Zenić, and M Zivković
May 1981, The Practitioner,
A Car, and I Jajić, and I Krampac, and M Vitaus, and N Zenić, and M Zivković
February 1978, Annals of the rheumatic diseases,
A Car, and I Jajić, and I Krampac, and M Vitaus, and N Zenić, and M Zivković
August 1985, Bollettino chimico farmaceutico,
A Car, and I Jajić, and I Krampac, and M Vitaus, and N Zenić, and M Zivković
August 1982, Rheumatology and rehabilitation,
A Car, and I Jajić, and I Krampac, and M Vitaus, and N Zenić, and M Zivković
January 1983, European journal of rheumatology and inflammation,
A Car, and I Jajić, and I Krampac, and M Vitaus, and N Zenić, and M Zivković
January 1978, Scandinavian journal of rheumatology. Supplement,
A Car, and I Jajić, and I Krampac, and M Vitaus, and N Zenić, and M Zivković
January 1978, Current medical research and opinion,
A Car, and I Jajić, and I Krampac, and M Vitaus, and N Zenić, and M Zivković
January 1981, Reumatizam,
Copied contents to your clipboard!